Practical considerations and radiation safety in radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin)GORDON, Leo I.Seminars in oncology. 2003, Vol 30, Num 6, pp 23-28, issn 0093-7754, 6 p., SUP17Article

Diagnostic and therapeutic advances in hematologic malignanciesTALLMAN, Martin S; GORDON, Leo I.Cancer treatment and research. 1999, Vol 99, issn 0927-3042, 384 p.Serial Issue

Transformation of follicular lymphoma to acute lymphoblastic leukemiaXIAOPING SUN; GORDON, Leo I; PETERSON, Loann C et al.Archives of pathology & laboratory medicine (1976). 2002, Vol 126, Num 8, pp 997-998, issn 0363-0153Article

Thrombotic microangiopathy in the cancer patientKWAAN, Hau C; GORDON, Leo I.Acta haematologica. 2001, Vol 106, Num 1-2, pp 52-56, issn 0001-5792Article

Novel treatment approaches for cutaneous T-cell lymphomaFOSS, F. M; KUZEL, T. M.Cancer treatment and research. 1999, Vol 99, pp 227-240, issn 0927-3042Article

Recent advances in the biology and management of acute lymphoblastic leukemia in adultsO'CONNOR, O. A; WEISS, M.Cancer treatment and research. 1999, Vol 99, pp 307-333, issn 0927-3042Article

New classifications for non-Hodgkin's lymphomaFINN, W. G; KROFT, S. H.Cancer treatment and research. 1999, Vol 99, pp 1-26, issn 0927-3042Article

Current approaches to acute promyelocytic leukemiaFRANKEL, S. R; POWELL, B. L.Cancer treatment and research. 1999, Vol 99, pp 125-153, issn 0927-3042Article

Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2ADARGART, Jamie L; FISH, Kamonwan; GORDON, Leo I et al.Antiviral research. 2012, Vol 95, Num 1, pp 49-56, issn 0166-3542, 8 p.Article

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignanciesBO SHI; HSU, Hsin-Ling; EVENS, Andy M et al.Blood. 2003, Vol 102, Num 1, pp 297-302, issn 0006-4971, 6 p.Article

The molecular biology of acute promyelocytic leukemiaSLACK, J. L; GALLAGHER, R. E.Cancer treatment and research. 1999, Vol 99, pp 75-124, issn 0927-3042Article

AIDS-associated lymphomaVOLM, M. D; VON ROENN, J. H.Cancer treatment and research. 1999, Vol 99, pp 241-266, issn 0927-3042Article

Motexafin Gadolinium Enhances p53-Mdm2 Interactions, Reducing p53 and Downstream Targets in Lymphoma Cell LinesSINGH, Amareshwar T. K; EVENS, Andrew M; PRACHAND, Sheila N et al.Anticancer research. 2010, Vol 30, Num 4, pp 1131-1136, issn 0250-7005, 6 p.Article

Advances in the therapy of the myelodysplastic syndromesKOUIDES, P. A; BENNETT, J. M.Cancer treatment and research. 1999, Vol 99, pp 335-362, issn 0927-3042Article

Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II studyEVENS, Andrew M; SMITH, Mitchell R; LOSSOS, Izidore S et al.British journal of haematology. 2014, Vol 166, Num 4, pp 514-520, issn 0007-1048, 7 p.Article

Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes databaseBAN-HOEFEN, Makiko; VANDERPLAS, Ann; RODRIGUEZ, Maria A et al.British journal of haematology. 2013, Vol 163, Num 4, pp 487-495, issn 0007-1048, 9 p.Article

Watchful Waiting in Low―Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study DatabaseSOLAL-CELIGNY, Philippe; BELLEI, Monica; DECONINCK, Eric et al.Journal of clinical oncology. 2012, Vol 30, Num 31, pp 3848-3853, issn 0732-183X, 6 p.Article

CD23+ Mantle Cell Lymphoma : A Clinical Pathologic Entity Associated With Superior Outcome Compared With CD23-DiseaseKELEMEN, Katalin; PETERSON, Loann C; GORDON, Leo I et al.American journal of clinical pathology. 2008, Vol 130, Num 2, pp 166-177, issn 0002-9173, 12 p.Article

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependentEVENS, Andrew M; PRACHAND, Sheila; BO SHI et al.Clinical cancer research. 2004, Vol 10, Num 4, pp 1481-1491, issn 1078-0432, 11 p.Article

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trialWISEMAN, Gregory A; GORDON, Leo I; GRILLO-LOPEZ, Antonio J et al.Blood. 2002, Vol 99, Num 12, pp 4336-4342, issn 0006-4971Article

Gene Expression―Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin LymphomaSCOTT, David W; CHAN, Fong Chun; WOOLCOCK, Bruce W et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 692-700, issn 0732-183X, 9 p.Article

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)GORDON, Leo I; FANGXIN HONG; ADVANI, Ranjana et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 684-691, issn 0732-183X, 8 p.Article

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496EVENS, Andrew M; FANGXIN HONG; STIFF, Patrick J et al.British journal of haematology. 2013, Vol 161, Num 1, pp 76-86, issn 0007-1048, 11 p.Article

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialARMAND, Philippe; NAGLER, Arnon; FAY, Joseph W et al.Journal of clinical oncology. 2013, Vol 31, Num 33, pp 4199-4206, issn 0732-183X, 8 p.Article

Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter AnalysisEVENS, Andrew M; ADVANI, Ranjana; KROLL-DESROSIERS, Aimee et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4132-4139, issn 0732-183X, 8 p.Conference Paper